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PLASMA CATECHOLAMINES IN ATOPIC DERMATITIS*
LAWRENCE M. SOLOMON, M.D. AND H. E. WENTZEL, M.D.
Atopic dermatitis is a characteristic hereditary
chronic dermatitis of poorly understood causa-
tion. The variety of theories (2, 3, 4, 5, 10, 14, 18
21, 25) devised to explain the various clinical and
biological aspects of this disease do not, by them-
selves, satisfactorily explain atopic dermatitis.
The existence of a possible defect of catechol-
amine metabolism in this disease is suggested by
the following frequently associated findings:
epinephrine-resistant eosinophilia under stress
(1); low blood pressure during exacerbation of
the disease (2); a "flat" glucose tolerance curve
(2); delayed accommodation to changes in
environmental temperature (3, 5, 10; and dis-
turbances in sweating (2, 21). Exacerbation of the
disease during periods of immunological, physical
and emotional stress is a well known and recorded
phenomenon (1, 2, 14, 18). Locally injected
stimuli such as acetylcholine, methacholine, and
carbachol results in cutaneous vasoconstriction
where vasodilation is the response in control
subjects (4). Although it has recently been
postulated (25) and demonstrated (23) that the
skin of patients with atopic dermatitis contains
an excess of acetylcholine, anticholinergic drugs
are clinically uneffective. A possible explanation
for this apparent contradiction may be found in
papers by Bum and Rand (17, 23) who believe
that acetylcholinc in the skin may mediate nor-
epinephrine release.
Further cutaneous abnormalities in the metab-
olism of norcpinephrine and epinephrine in atopic
dermatitis is suggested by Juhlin who found that
extremely low concentrations of norepinephrine
or epinephrine produces blanching in the skin of
patients with atopic dermatitis (4, 12). Juhlin
interprets this difference to be an expression of
increased sensitivity to catccholamines of the
cutaneous blood vessels in patients with atopic
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dermatitis. He also found that norepinephrine,
when introduced into the skin by iontophoresis,
remains in. situ longer in patients with atopic der-
matitis than in patients with other dermatoses
(13). He further demonstrated that the "delayed
blanch" phenomenon may become a normal re-
sponse by pretreating the skin with iontophoreti-
cally injected guancthidine (24).
Since these systemic and cutaneous findings
could conceivably be related to an altered distri-
bution of catecholamines between skin and
plasma in patients with acute atopic dermatitis,
it is of interest to compare the plasma levels of
epincphrine and norepinephrine in patients with
acute atopic dermatitis with those of patients
with atopic dermatitis in remission and patients
with other dermatoses, and we attempted to
determine their levels in a small number of
patients.
METHOD
The subjects were four female patients, age 15
to 21, with extensive acute atopie dermatitis
diagnosed by the usual criteria (2), one girl of 15
with atopie dermatitisn i remission, and 2 females
and 3 males age 19 to 60, with dermatitis herpeti-
formis, psoriasis, erythema multiforme, furuncle
and normal skin. One atopic patient's plasma was
examined both during the acute phase and during
remission. None of the patients were smokers,
nor were they receiving medication of any sort
except for the patient with psoriasis who was
later found to be taking reserpine. The blood for
catecholamine determination was drawn under
standard conditions of physical and mental
activity, at the same time of day.
The cateeholamines (epinephrine and norepi-
nephrine) were determined (determinations were
done with the assistance of Drs. Levin and Parkins
of the Harrison Department of Surgical Research,
School of Medicine, of the University of Pennsyl-
vania) on 20 ml aliquots of venous blood that were
immediately iced, centrifuged and the blood
plasma aspirated into cooled tubes. The eate-
eholamines were absorbed on alumina using a
batch method as described by Goldfein and his
group (7). The concentrations of epinephrine and
norepinephrine were determined by the trihy-
droxy indole amine method described by Price
and Price (6).
RE5ULT5
(See Table I) Three patients with acute atopic
dermatitis were found to have no measurable
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TABLE I
Diagnosis Age
Norepineph-
(Gamma %)
Normal
0.01—0.06
Epinephrine
0 0 02—
Acute atopic 16 0.600 0.000
Same patient in 0.220 0.160
remission
Acute atopie 21 0.000 0.000
Acute atopie 21 0.000 0.000
Acute atopie 15 0.016 0.020
Atopie in remission 15 0.088 0.000
Dermatitis herpeti- 60 0.320 0.240
formis
Psoriasis (on reser- 47 0.000 0.170
pine)
Furuncle 28 0.046 0.000
Erythemn multi- 19 0.076 0.008
forme
Normal exercised 30 0.160 0.000
subject
0.005Acute atopie mean 0.004
levels
Controls—mean 0.130 0.082
levels
circulating cateeholamines. The fourth patient
was found to have 0.016 gamma per cent nor-
epinephrine and 0.020 gamma pee cent epineph-
rine. The patient with psoriasis also had no
demonstrable norepinephrine. The other control
subjects, including the two patients with atopie
dermatitis in remission were found to have levels
of norepinephrine up to 0.320 gamma per cent
and epinehprine up to 0.24 gamma per cent. The
mean values for the atopic group were: norepi-
nephrine 0.004 gamma per cent, and epinephrine
0.005 gamma per cent. The mean values for the
control group were: norepinephrine 0.130 gamma
per cent and epinephrine 0.82 gamma per cent.
DISCUSSION
The advantages and limitations of the various
physical-chemical procedures which have been
devised for detecting the minute quantities of
epinephrine and norepinephrine present in plasma
have been fully discussed in the literature (6, 7, 9,
19, 20, 16, 22). We have employed the trihydroxy
indole amine method as described by Price and
Price (6) using a batch method for preparing the
eluate, as described by Goldfein and his group (7).
Although there are limitations to the degrees of
sensitivity and specificity which can be obtained
(6, 9, 16, 19, 20, 22), the fluorescent technic ap-
pears to be the best suited to this study because it
possesses a high degree of sensitivity necessary to
detect minute quantities of eateeholamine (7, 19,
20, 22). rrhe trihydroxy indole amine method is
said to be the most specific of the fluorescent
methods available for the determination of nor-
epinephrine and epinephrine (19, 6, 20). The
normal adult venous plasma levels for norepi-
nephrine using the trihydroxyindole amine method
have been in the range of .03 gamma per cent
(6, 19, 20). Our values in the control group were
somewhat higher (mean value 0.120 gamma per
cent) but it must be remembered that with one
exception these patients were all suffering from a
skin disease and could not be considered "nor-
mal". The normal values for epinephrine using
this method is 0-4102 gamma per cent and one
therefore cannot speak of a "decreased" level
of epinephrine.
Three of our patients with acute atopic derma-
titis, under a stressful situation exhibited no
fluorescence in their plasma, (norepinephrine and
epinephrine hands). One of these three, later, in
remission, showed normal amounts of both nor-
epinephrine and epinephrine. The fourth patient
exhibited a minimal amount of fluorescence in
both bands. The patient with psoriasis, later
found to be taking reserpine, showed no norepi-
nephrine but a measurable amount of epinephrine.
We found a decreased level of norepinephrine
and epinephrine in the plasma of patients with
atopie dermatitis as compared with one patient
with quiescent atopic dermatitis or control sub-
jects with other dermatoses. This apparent de-
crease of norepinephrine in acute atopie derma-
titis may be contrasted, not only to other
dermatoses, but also to an increase which has
been demonstrated in the plasma of patients
under other forms of physical or emotional stress
(7, 8). The epinephrine leveLs were not measurable
in several patients, but not consistently in the
atopie group.
Since norepinephrine is derived primarily from
sympathetic nerve endings (17) in normal sub-
jects, the plasma norepinephrine represents es-
sentially the small amount of this eateeholamine
which diffuses into the circulation before being
metabolized (7). The various physiological ab-
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normalities enumerated in the introduction as
well as the cutaneous affinity for catecholamines
demonstrated in atopic dermatitis (12, 4, 13)
would suggest that during a flare of this disease,
norepinehprine cannot "escape" into the circula-
tion and therefore may be abnormally hound in
the skin (23). Although our series is too small to
speak of statistical significance, and only indicate
a trend to be verified, the demonstration of low
levels of norepinephrine in the plasma of patients
with acute dermatitis, the recovery of normal
levels in the plasma of one patient in remission
who had been found to have no measurable
quantity during a flare of acute atopie dermatitis,
as well as the beneficial effects of guanethidine
which has been demonstrated by Viglioglia as
well as by us on the pruritus of this disease (10,
15) supports this hypothesis.
SUMMARY
Four patients with acute atopic dermatitis
were found to have diminished or non-measurable
quantities of norepinephrine in their plasma when
compared with two patients with atopie derma-
titis in remission or four patients with a variety
of other dermatoses. One of these, when in remis-
sion, exhibited normal values. This finding to-
gether with past observations on metabolic ab-
normalities in patients with atopic dermatitis
supports an hypothesis that there may be an
abnormal binding of norepinephrine in the skin
of patients during an acute exacerbation of atopic
dermatitis.
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